Facet browsing currently unavailable
Page 2 of 265 results
Sort by: relevance publication year
Improved synthesis of SV2A targeting radiotracer [11C]UCB-J JOURNAL ARTICLE published December 2019 in EJNMMI Radiopharmacy and Chemistry Research funded by H2020 Marie Skłodowska-Curie Actions (No 813528) |
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET JOURNAL ARTICLE published 13 December 2022 in EJNMMI Radiopharmacy and Chemistry Research funded by Cancer Research UK (A13827,A25006) | Beatson Cancer Charity (Beatson Cancer Charity) |
A novel PET probe to selectively image heat shock protein 90α/β isoforms in the brain JOURNAL ARTICLE published 4 March 2024 in EJNMMI Radiopharmacy and Chemistry Research funded by JSPS KAKENHI (JP22K15874) | Collaborative Research Project of the Brain Research Institute, Niigata University, Niigata, Japan (22503) | Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology, Obu, Japan (21-43) |
Are we “preparing” radiopharmaceuticals? JOURNAL ARTICLE published January 2017 in EJNMMI Radiopharmacy and Chemistry |
Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2 JOURNAL ARTICLE published 2 January 2024 in EJNMMI Radiopharmacy and Chemistry |
Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators JOURNAL ARTICLE published December 2021 in EJNMMI Radiopharmacy and Chemistry |
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? JOURNAL ARTICLE published 3 August 2023 in EJNMMI Radiopharmacy and Chemistry |
Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators JOURNAL ARTICLE published 17 April 2024 in EJNMMI Radiopharmacy and Chemistry |
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators JOURNAL ARTICLE published December 2020 in EJNMMI Radiopharmacy and Chemistry |
Synthesis of [18F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective JOURNAL ARTICLE published 10 March 2023 in EJNMMI Radiopharmacy and Chemistry |
Correction: Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding JOURNAL ARTICLE published 19 March 2024 in EJNMMI Radiopharmacy and Chemistry |
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET JOURNAL ARTICLE published 6 March 2024 in EJNMMI Radiopharmacy and Chemistry Research funded by Vetenskapsrådet (2021-01083,2021-03524,2022-04831) | HORIZON EUROPE Marie Sklodowska-Curie Actions (813528) |
First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs JOURNAL ARTICLE published 30 June 2023 in EJNMMI Radiopharmacy and Chemistry Research funded by KWF Kankerbestrijding (12259) |
Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer JOURNAL ARTICLE published December 2019 in EJNMMI Radiopharmacy and Chemistry Research funded by KWF Kankerbestrijding (10099) | Innovative Medicines Initiative (116106) | Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91617039) |
Highlight selection of radiochemistry and radiopharmacy developments by editorial board JOURNAL ARTICLE published 16 May 2024 in EJNMMI Radiopharmacy and Chemistry |
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go? JOURNAL ARTICLE published 12 October 2023 in EJNMMI Radiopharmacy and Chemistry Research funded by Horizon 2020 research and innovation programme (No 101008571) |
Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab′)2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab′)2 – implications for a PET theranostic strategy JOURNAL ARTICLE published December 2021 in EJNMMI Radiopharmacy and Chemistry Research funded by Canadian Cancer Society (Innovation-to-Impact Grant) | Government of Ontario (QEII-GSST Scholarship) | University of Toronto (CPO Scholarship,CPO Scholarship,Second Reuben Wells Fellowship,University College Alumni Scholarship) | Terry Fox Foundation (STARS21 Scholarship) | amgen canada (Materials Transfer Agreement) |
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac JOURNAL ARTICLE published December 2019 in EJNMMI Radiopharmacy and Chemistry Research funded by NSERC Discovery (00) | National Research Council of Canada (n/a) |
Unnatural amino acid substitutions to improve in vivo stability and tumor uptake of 68Ga-labeled GRPR-targeted TacBOMB2 derivatives for cancer imaging with positron emission tomography JOURNAL ARTICLE published 2 February 2024 in EJNMMI Radiopharmacy and Chemistry Research funded by Canadian Institutes of Health Research (PJT-162243,PJT-180300,PJT-183956) |
Production of novel diagnostic radionuclides in small medical cyclotrons JOURNAL ARTICLE published December 2018 in EJNMMI Radiopharmacy and Chemistry |